Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
E-pub ahead of print

Early- and late onset post-transplant lymphoproliferative disorders (PTLD) among adult kidney and liver transplant recipients

Research output: Contribution to journalJournal articlepeer-review

DOI

  1. Markers of obesity in Danish pediatric liver transplantation recipients

    Research output: Contribution to journalJournal articlepeer-review

  2. Characteristics and Outcomes of Patients with Delftia acidovorans Infections: a Retrospective Cohort Study

    Research output: Contribution to journalJournal articlepeer-review

  3. High incidence of subclinical peripheral artery disease in people with HIV

    Research output: Contribution to journalJournal articlepeer-review

View graph of relations

OBJECTIVES: Posttransplant lymphoproliferative disorder (PTLD) in solid organ transplant recipients has a high mortality and may present early (<2 years) or late (≥2 years) posttransplantation. We investigated the clinical characteristics of early and late PTLD among kidney and liver transplant recipients.

METHODS: Recipients, transplanted at Rigshospitalet, with PTLD development as adults from January 2010 to August 2020, were included. Clinical characteristics, laboratory parameters, and pathology of early and late PTLD were compared.

RESULTS: Thirty-one PTLD cases were detected where 10 (32%) were early and 21 (68%) were late PTLD. EBV DNA in plasma was detected in 78% versus 28% in early and late PTLD (p = .037). None of the recipients with early PTLD and nine recipients with late PTLD (47%) had Ann Arbor stage IV at the time of their diagnosis (p = .006). Cyclophosphamid-Hydroxyrubicin-Oncovin-Prednisolon was used for treatment in 10 (48%) recipients with late PTLD (p = 0.032) only. There was no difference in mortality between the two groups.

CONCLUSIONS: Recipients with late PTLD had a lower prevalence of detectable EBV DNA in plasma, were diagnosed with more advanced disease, and were more frequently treated with chemotherapy compared to recipients with early PTLD.

Original languageEnglish
JournalEuropean Journal of Haematology
ISSN0902-4441
DOIs
Publication statusE-pub ahead of print - 19 Jun 2022

Bibliographical note

This article is protected by copyright. All rights reserved.

ID: 79115025